CRISPR mouse models show EML4-ALK fusion variants alter drug response, suggesting a need for variant-specific treatment.
This year’s WIRED Health summit in Boston featured Moderna CEO Stéphane Bancel, CNN chief medical correspondent Sanjay Gupta, ...
About 5% of lung adenocarcinomas, one of the most common forms of lung cancer, are driven by a faulty fusion of two genes, ...
Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...
News-Medical.Net on MSN
Study reveals a new oncogenic role of NBL1 in ovarian cancer metastasis
Ovarian cancer (OC), one of the three most common gynecological malignancies, is characterized by low early detection rates ...
News-Medical.Net on MSN
New screening method boosts efficiency and accuracy of CAST genome editing
Natural systems such as CRISPR-associated transposons (CASTs) offer a targetable, one-step way to edit genomes.
Researchers unveiled a genetic editing method that uses small nuclear RNAs instead of CRISPR. This approach produced fewer ...
UNIVERSITY CITY (WPVI) -- The first attempt in the United States to use a gene-editing tool called CRISPR against cancer seems safe in the three patients who have had it so far, but it's too soon to ...
A CRISPR system detects rare cancer mutations in blood with single-nucleotide precision, outperforming ddPCR through engineered RNA guides and isothermal amplification. (Nanowerk Spotlight) Hidden ...
CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...
Gene-edited pancreatic cells have been transplanted into a patient with type 1 diabetes for the first time. They produced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results